Back to PFE Stock Lookup
Pages: 1 2 »» Last Page

Pfizer (PFE) – Press Releases

Oct 29, 2014 02:44 PM Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults
Oct 29, 2014 08:30 AM Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder
Oct 27, 2014 08:05 AM DURECT Provides Update on REMOXY® and POSIDUR™ Programs
Oct 27, 2014 08:00 AM Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII
Oct 23, 2014 04:05 PM Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend
Oct 23, 2014 08:00 AM Pfizer Wins SUTENT® Patent Case In Delaware District Court
Oct 20, 2014 09:00 AM ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S.
Oct 17, 2014 04:38 PM FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII
Oct 13, 2014 08:00 AM Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review
Oct 10, 2014 08:00 AM Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™
Oct 8, 2014 08:30 AM Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer
Oct 8, 2014 08:00 AM Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vacci
Oct 2, 2014 05:10 PM Zoetis Declares Fourth Quarter 2014 Dividend
Oct 1, 2014 08:00 AM Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance
Sep 30, 2014 08:30 AM Zoetis to Host Webcast and Conference Call on Third Quarter 2014 Financial Results
Sep 29, 2014 08:00 PM Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study
Sep 26, 2014 09:01 AM GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel
Sep 26, 2014 07:30 AM Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch
Sep 25, 2014 08:00 AM Pfizer Completes Acquisition Of InnoPharma
Sep 23, 2014 10:00 AM Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts
Sep 23, 2014 08:00 AM Kim Cattrall Encourages Women to Embrace Menopause with Style
Sep 22, 2014 08:00 AM Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers
Sep 19, 2014 08:00 AM Pfizer Foundation Provides $2 Million In Grants To Support ‘Last-Mile’ Vaccine Coverage In Africa
Sep 16, 2014 08:30 AM Zoetis Ranked Among Top Ten Companies for Working Mothers
Sep 3, 2014 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Sep 3, 2014 08:00 AM Zoetis Granted Conditional License for Porcine Epidemic Diarrhea Vaccine*
Aug 30, 2014 05:15 AM Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Pa
Aug 29, 2014 10:13 AM InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®
Aug 28, 2014 01:15 PM Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease
Aug 28, 2014 08:00 AM Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation
Aug 26, 2014 08:00 AM Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
Aug 25, 2014 09:00 AM Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
Aug 22, 2014 03:46 PM ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
Aug 21, 2014 01:31 PM U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy
Aug 21, 2014 08:00 AM Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer
Aug 20, 2014 08:30 AM Zoetis to Participate in Bank of America Merrill Lynch Global Healthcare Conference
Aug 20, 2014 08:00 AM Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014
Aug 18, 2014 08:00 AM Pfizer Announces Submission of Palbociclib New Drug Application to the FDA
Aug 14, 2014 05:01 PM Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine
Aug 14, 2014 04:30 PM Zoetis Announces Appointment of Paul Herendeen as Executive Vice President and Chief Financial Officer
Aug 14, 2014 08:00 AM Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent for Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform
Aug 13, 2014 05:42 PM Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older
Aug 13, 2014 10:23 AM RiverVest Venture Partners’ Otonomy Completes $100 Million Initial Public Offering
Aug 13, 2014 09:00 AM Zoetis to Participate in Morgan Stanley Global Healthcare Conference
Aug 12, 2014 05:01 PM Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy Lyrica® Studies Conducted in China
Aug 7, 2014 08:00 AM European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults
Aug 6, 2014 08:00 AM Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer
Aug 5, 2014 08:15 AM Zoetis Will Hold Its Inaugural Investor Day on November 18
Aug 5, 2014 08:00 AM Pain Therapeutics Reports Q2 2014 Financial Results
Pages: 1 2 »» Last Page

Back to PFE Stock Lookup